MedTrace Logo

Extra Virgin Olive Oil on Glycemic Control ,Insulin Resistance and Insulin Secretion

NCT03891927 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-04-01

No results posted yet for this study

Summary

Aim of this study to evaluate the effects of extra virgin olive oil on glycemic control ,insulin resistance and insulin secretion in patients with Type 2 diabetics.

Conditions

Interventions

DIETARY_SUPPLEMENT

extra virgin olive oil

During the experimental period (3 months ), participants will be requested to consume daily dose of 30 mL (3 tablespoons) of HP-EVOO

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Salah Abdelazeem Argoon, professor · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2020-11-01
Completion
2020-12-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03891927 on ClinicalTrials.gov